 | • レポートコード：QYR2104Z4009 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ナノメディシンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（量子ドット、ナノ粒子、ナノシェル、ナノチューブ、ナノデバイス）、用途別市場規模（腫瘍、感染症、循環器、整形外科、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ナノメディシンの市場動向 ・企業の競争状況、市場シェア ・ナノメディシンの種類別市場規模（量子ドット、ナノ粒子、ナノシェル、ナノチューブ、ナノデバイス） ・ナノメディシンの用途別市場規模（腫瘍、感染症、循環器、整形外科、その他） ・ナノメディシンの北米市場規模2016-2027（アメリカ、カナダ） ・ナノメディシンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ナノメディシンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ナノメディシンの中南米市場規模2016-2027（メキシコ、ブラジル） ・ナノメディシンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Combimatrix、Ablynx、Abraxis Bioscience、Celgene、Mallinckrodt、Arrowhead Research、GE Healthcare、Merck、Pfizer、Nanosphere、Epeius Biotechnologies、Cytimmune Sciences、Nanospectra Biosciences） ・結論 |
Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.
Market Analysis and Insights: Global Nanomedicine Market
The global Nanomedicine market size is projected to reach US$ 232 million by 2026, from US$ 150 million in 2019, at a CAGR of 6.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nanomedicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nanomedicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nanomedicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nanomedicine market.
Global Nanomedicine Scope and Market Size
Nanomedicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nanomedicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Segment by Application
oncology
Infectious diseases
Cardiology
Orthopedics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Celgene
Mallinckrodt
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanomedicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Quantum dots
1.2.3 Nanoparticles
1.2.4 Nanoshells
1.2.5 Nanotubes
1.2.6 Nanodevices
1.3 Market by Application
1.3.1 Global Nanomedicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 oncology
1.3.3 Infectious diseases
1.3.4 Cardiology
1.3.5 Orthopedics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nanomedicine Market Perspective (2016-2027)
2.2 Nanomedicine Growth Trends by Regions
2.2.1 Nanomedicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nanomedicine Historic Market Share by Regions (2016-2021)
2.2.3 Nanomedicine Forecasted Market Size by Regions (2022-2027)
2.3 Nanomedicine Industry Dynamic
2.3.1 Nanomedicine Market Trends
2.3.2 Nanomedicine Market Drivers
2.3.3 Nanomedicine Market Challenges
2.3.4 Nanomedicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanomedicine Players by Revenue
3.1.1 Global Top Nanomedicine Players by Revenue (2016-2021)
3.1.2 Global Nanomedicine Revenue Market Share by Players (2016-2021)
3.2 Global Nanomedicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nanomedicine Revenue
3.4 Global Nanomedicine Market Concentration Ratio
3.4.1 Global Nanomedicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanomedicine Revenue in 2020
3.5 Nanomedicine Key Players Head office and Area Served
3.6 Key Players Nanomedicine Product Solution and Service
3.7 Date of Enter into Nanomedicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanomedicine Breakdown Data by Type
4.1 Global Nanomedicine Historic Market Size by Type (2016-2021)
4.2 Global Nanomedicine Forecasted Market Size by Type (2022-2027)
5 Nanomedicine Breakdown Data by Application
5.1 Global Nanomedicine Historic Market Size by Application (2016-2021)
5.2 Global Nanomedicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Nanomedicine Market Size (2016-2027)
6.2 North America Nanomedicine Market Size by Type
6.2.1 North America Nanomedicine Market Size by Type (2016-2021)
6.2.2 North America Nanomedicine Market Size by Type (2022-2027)
6.2.3 North America Nanomedicine Market Size by Type (2016-2027)
6.3 North America Nanomedicine Market Size by Application
6.3.1 North America Nanomedicine Market Size by Application (2016-2021)
6.3.2 North America Nanomedicine Market Size by Application (2022-2027)
6.3.3 North America Nanomedicine Market Size by Application (2016-2027)
6.4 North America Nanomedicine Market Size by Country
6.4.1 North America Nanomedicine Market Size by Country (2016-2021)
6.4.2 North America Nanomedicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Nanomedicine Market Size (2016-2027)
7.2 Europe Nanomedicine Market Size by Type
7.2.1 Europe Nanomedicine Market Size by Type (2016-2021)
7.2.2 Europe Nanomedicine Market Size by Type (2022-2027)
7.2.3 Europe Nanomedicine Market Size by Type (2016-2027)
7.3 Europe Nanomedicine Market Size by Application
7.3.1 Europe Nanomedicine Market Size by Application (2016-2021)
7.3.2 Europe Nanomedicine Market Size by Application (2022-2027)
7.3.3 Europe Nanomedicine Market Size by Application (2016-2027)
7.4 Europe Nanomedicine Market Size by Country
7.4.1 Europe Nanomedicine Market Size by Country (2016-2021)
7.4.2 Europe Nanomedicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicine Market Size (2016-2027)
8.2 Asia-Pacific Nanomedicine Market Size by Type
8.2.1 Asia-Pacific Nanomedicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nanomedicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nanomedicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Nanomedicine Market Size by Application
8.3.1 Asia-Pacific Nanomedicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nanomedicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nanomedicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Nanomedicine Market Size by Region
8.4.1 Asia-Pacific Nanomedicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nanomedicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nanomedicine Market Size (2016-2027)
9.2 Latin America Nanomedicine Market Size by Type
9.2.1 Latin America Nanomedicine Market Size by Type (2016-2021)
9.2.2 Latin America Nanomedicine Market Size by Type (2022-2027)
9.2.3 Latin America Nanomedicine Market Size by Type (2016-2027)
9.3 Latin America Nanomedicine Market Size by Application
9.3.1 Latin America Nanomedicine Market Size by Application (2016-2021)
9.3.2 Latin America Nanomedicine Market Size by Application (2022-2027)
9.3.3 Latin America Nanomedicine Market Size by Application (2016-2027)
9.4 Latin America Nanomedicine Market Size by Country
9.4.1 Latin America Nanomedicine Market Size by Country (2016-2021)
9.4.2 Latin America Nanomedicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicine Market Size (2016-2027)
10.2 Middle East & Africa Nanomedicine Market Size by Type
10.2.1 Middle East & Africa Nanomedicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nanomedicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nanomedicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Nanomedicine Market Size by Application
10.3.1 Middle East & Africa Nanomedicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nanomedicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nanomedicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Nanomedicine Market Size by Country
10.4.1 Middle East & Africa Nanomedicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nanomedicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Combimatrix
11.1.1 Combimatrix Company Details
11.1.2 Combimatrix Business Overview
11.1.3 Combimatrix Nanomedicine Introduction
11.1.4 Combimatrix Revenue in Nanomedicine Business (2016-2021)
11.1.5 Combimatrix Recent Development
11.2 Ablynx
11.2.1 Ablynx Company Details
11.2.2 Ablynx Business Overview
11.2.3 Ablynx Nanomedicine Introduction
11.2.4 Ablynx Revenue in Nanomedicine Business (2016-2021)
11.2.5 Ablynx Recent Development
11.3 Abraxis Bioscience
11.3.1 Abraxis Bioscience Company Details
11.3.2 Abraxis Bioscience Business Overview
11.3.3 Abraxis Bioscience Nanomedicine Introduction
11.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2016-2021)
11.3.5 Abraxis Bioscience Recent Development
11.4 Celgene
11.4.1 Celgene Company Details
11.4.2 Celgene Business Overview
11.4.3 Celgene Nanomedicine Introduction
11.4.4 Celgene Revenue in Nanomedicine Business (2016-2021)
11.4.5 Celgene Recent Development
11.5 Mallinckrodt
11.5.1 Mallinckrodt Company Details
11.5.2 Mallinckrodt Business Overview
11.5.3 Mallinckrodt Nanomedicine Introduction
11.5.4 Mallinckrodt Revenue in Nanomedicine Business (2016-2021)
11.5.5 Mallinckrodt Recent Development
11.6 Arrowhead Research
11.6.1 Arrowhead Research Company Details
11.6.2 Arrowhead Research Business Overview
11.6.3 Arrowhead Research Nanomedicine Introduction
11.6.4 Arrowhead Research Revenue in Nanomedicine Business (2016-2021)
11.6.5 Arrowhead Research Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Nanomedicine Introduction
11.7.4 GE Healthcare Revenue in Nanomedicine Business (2016-2021)
11.7.5 GE Healthcare Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Nanomedicine Introduction
11.8.4 Merck Revenue in Nanomedicine Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Nanomedicine Introduction
11.9.4 Pfizer Revenue in Nanomedicine Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Nanosphere
11.10.1 Nanosphere Company Details
11.10.2 Nanosphere Business Overview
11.10.3 Nanosphere Nanomedicine Introduction
11.10.4 Nanosphere Revenue in Nanomedicine Business (2016-2021)
11.10.5 Nanosphere Recent Development
11.11 Epeius Biotechnologies
11.11.1 Epeius Biotechnologies Company Details
11.11.2 Epeius Biotechnologies Business Overview
11.11.3 Epeius Biotechnologies Nanomedicine Introduction
11.11.4 Epeius Biotechnologies Revenue in Nanomedicine Business (2016-2021)
11.11.5 Epeius Biotechnologies Recent Development
11.12 Cytimmune Sciences
11.12.1 Cytimmune Sciences Company Details
11.12.2 Cytimmune Sciences Business Overview
11.12.3 Cytimmune Sciences Nanomedicine Introduction
11.12.4 Cytimmune Sciences Revenue in Nanomedicine Business (2016-2021)
11.12.5 Cytimmune Sciences Recent Development
11.13 Nanospectra Biosciences
11.13.1 Nanospectra Biosciences Company Details
11.13.2 Nanospectra Biosciences Business Overview
11.13.3 Nanospectra Biosciences Nanomedicine Introduction
11.13.4 Nanospectra Biosciences Revenue in Nanomedicine Business (2016-2021)
11.13.5 Nanospectra Biosciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Nanomedicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Quantum dots
Table 3. Key Players of Nanoparticles
Table 4. Key Players of Nanoshells
Table 5. Key Players of Nanotubes
Table 6. Key Players of Nanodevices
Table 7. Global Nanomedicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Nanomedicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Nanomedicine Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Nanomedicine Market Share by Regions (2016-2021)
Table 11. Global Nanomedicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Nanomedicine Market Share by Regions (2022-2027)
Table 13. Nanomedicine Market Trends
Table 14. Nanomedicine Market Drivers
Table 15. Nanomedicine Market Challenges
Table 16. Nanomedicine Market Restraints
Table 17. Global Nanomedicine Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Nanomedicine Market Share by Players (2016-2021)
Table 19. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanomedicine as of 2020)
Table 20. Ranking of Global Top Nanomedicine Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Nanomedicine Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nanomedicine Product Solution and Service
Table 24. Date of Enter into Nanomedicine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nanomedicine Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Nanomedicine Revenue Market Share by Type (2016-2021)
Table 28. Global Nanomedicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Nanomedicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Nanomedicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Nanomedicine Revenue Market Share by Application (2016-2021)
Table 32. Global Nanomedicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Nanomedicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Nanomedicine Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Nanomedicine Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Nanomedicine Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Nanomedicine Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Nanomedicine Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Nanomedicine Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Nanomedicine Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Nanomedicine Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Nanomedicine Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Nanomedicine Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Nanomedicine Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Nanomedicine Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Nanomedicine Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Nanomedicine Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Nanomedicine Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Nanomedicine Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Nanomedicine Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Nanomedicine Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Nanomedicine Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Nanomedicine Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Nanomedicine Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Nanomedicine Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Nanomedicine Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Nanomedicine Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Nanomedicine Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Nanomedicine Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Nanomedicine Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Nanomedicine Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Nanomedicine Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Nanomedicine Market Size by Country (2022-2027) & (US$ Million)
Table 64. Combimatrix Company Details
Table 65. Combimatrix Business Overview
Table 66. Combimatrix Nanomedicine Product
Table 67. Combimatrix Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 68. Combimatrix Recent Development
Table 69. Ablynx Company Details
Table 70. Ablynx Business Overview
Table 71. Ablynx Nanomedicine Product
Table 72. Ablynx Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 73. Ablynx Recent Development
Table 74. Abraxis Bioscience Company Details
Table 75. Abraxis Bioscience Business Overview
Table 76. Abraxis Bioscience Nanomedicine Product
Table 77. Abraxis Bioscience Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 78. Abraxis Bioscience Recent Development
Table 79. Celgene Company Details
Table 80. Celgene Business Overview
Table 81. Celgene Nanomedicine Product
Table 82. Celgene Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 83. Celgene Recent Development
Table 84. Mallinckrodt Company Details
Table 85. Mallinckrodt Business Overview
Table 86. Mallinckrodt Nanomedicine Product
Table 87. Mallinckrodt Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 88. Mallinckrodt Recent Development
Table 89. Arrowhead Research Company Details
Table 90. Arrowhead Research Business Overview
Table 91. Arrowhead Research Nanomedicine Product
Table 92. Arrowhead Research Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 93. Arrowhead Research Recent Development
Table 94. GE Healthcare Company Details
Table 95. GE Healthcare Business Overview
Table 96. GE Healthcare Nanomedicine Product
Table 97. GE Healthcare Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 98. GE Healthcare Recent Development
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 102. Merck Recent Development
Table 103. Pfizer Company Details
Table 104. Pfizer Business Overview
Table 105. Pfizer Nanomedicine Product
Table 106. Pfizer Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 107. Pfizer Recent Development
Table 108. Nanosphere Company Details
Table 109. Nanosphere Business Overview
Table 110. Nanosphere Nanomedicine Product
Table 111. Nanosphere Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 112. Nanosphere Recent Development
Table 113. Epeius Biotechnologies Company Details
Table 114. Epeius Biotechnologies Business Overview
Table 115. Epeius Biotechnologies Nanomedicine Product
Table 116. Epeius Biotechnologies Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 117. Epeius Biotechnologies Recent Development
Table 118. Cytimmune Sciences Company Details
Table 119. Cytimmune Sciences Business Overview
Table 120. Cytimmune Sciences Nanomedicine Product
Table 121. Cytimmune Sciences Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 122. Cytimmune Sciences Recent Development
Table 123. Nanospectra Biosciences Company Details
Table 124. Nanospectra Biosciences Business Overview
Table 125. Nanospectra Biosciences Nanomedicine Product
Table 126. Nanospectra Biosciences Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 127. Nanospectra Biosciences Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanomedicine Market Share by Type: 2020 VS 2027
Figure 2. Quantum dots Features
Figure 3. Nanoparticles Features
Figure 4. Nanoshells Features
Figure 5. Nanotubes Features
Figure 6. Nanodevices Features
Figure 7. Global Nanomedicine Market Share by Application: 2020 VS 2027
Figure 8. oncology Case Studies
Figure 9. Infectious diseases Case Studies
Figure 10. Cardiology Case Studies
Figure 11. Orthopedics Case Studies
Figure 12. Others Case Studies
Figure 13. Nanomedicine Report Years Considered
Figure 14. Global Nanomedicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Nanomedicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Nanomedicine Market Share by Regions: 2020 VS 2027
Figure 17. Global Nanomedicine Market Share by Regions (2022-2027)
Figure 18. Global Nanomedicine Market Share by Players in 2020
Figure 19. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanomedicine as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Nanomedicine Revenue in 2020
Figure 21. Global Nanomedicine Revenue Market Share by Type (2016-2021)
Figure 22. Global Nanomedicine Revenue Market Share by Type (2022-2027)
Figure 23. North America Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Nanomedicine Market Share by Type (2016-2027)
Figure 25. North America Nanomedicine Market Share by Application (2016-2027)
Figure 26. North America Nanomedicine Market Share by Country (2016-2027)
Figure 27. United States Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Nanomedicine Market Share by Type (2016-2027)
Figure 31. Europe Nanomedicine Market Share by Application (2016-2027)
Figure 32. Europe Nanomedicine Market Share by Country (2016-2027)
Figure 33. Germany Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Nanomedicine Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Nanomedicine Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Nanomedicine Market Share by Region (2016-2027)
Figure 43. China Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Nanomedicine Market Share by Type (2016-2027)
Figure 51. Latin America Nanomedicine Market Share by Application (2016-2027)
Figure 52. Latin America Nanomedicine Market Share by Country (2016-2027)
Figure 53. Mexico Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Nanomedicine Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Nanomedicine Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Nanomedicine Market Share by Country (2016-2027)
Figure 59. Turkey Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Combimatrix Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 63. Ablynx Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 64. Abraxis Bioscience Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 65. Celgene Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 66. Mallinckrodt Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 67. Arrowhead Research Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 68. GE Healthcare Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 71. Nanosphere Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 72. Epeius Biotechnologies Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 73. Cytimmune Sciences Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 74. Nanospectra Biosciences Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の医療用ナノテクノロジー（ナノ医療）市場規模・現状・予測（2021年-2027年） It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular lev…- ナノ医療の世界市場2020年：分析と予測（～2025年） This report describes the global market size of Nanomedicine from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For geography segment, regional supply, demand, major players, price is presented from 2015 to 2025. Th…
- 世界のPOC感染症市場規模・現状・予測（2021年-2027年） POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care. Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted peri…
- 世界の感染症市場規模・現状・予測（2021年-2027年） When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antip…
- 世界のナノメディシン市場規模・現状・予測（2021年-2027年） Nanotechnology refers to the engineering of functional systems at the molecular scale. It includes construction of items from the bottom up, using modern techniques and tools to make complete, high-performance products. Nanomedicines refer to medications that are based on the application of nanotech…